TTNP TITAN PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Agreement with Brian Crowley Titan Pharmaceuticals, Inc. reached an agreement with Brian Crowley to remain as Senior VP Finance and principal accounting officer until May 15, 2024.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC